ICMI 2015

F.23 Oral Challenge with Wild-type Salmonella Typhi Induces Distinct Changes in B cell Subsets in Individuals Who Develop Typhoid Disease

Friday, July 17, 2015
Grand Hall and Gallery, Ground Floor & 1st Floor (Maritim Hotel)
Franklin Toapanta , CVD - University of Maryland - Baltimore, Baltimore, MD, United States
Paula Bernal , University of Maryland Baltimore, Baltimore, MD, United States
Stephanie Fresnay , Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD
Thomas Darton , Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom
Claire Jones , Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom
Claire Waddington , Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom
Christoph Blohmke , Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom
Gordon Dougan , Microbial Pathogenesis Group, Wellcome Trust Sanger Institute, Hinxton, United Kingdom
Brian Angus , Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
Myron Levine , Center for Vaccine Development, University of Maryland School of Medicine, Oxford, MD
Andrew Pollard , Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom
Marcelo Sztein , Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD
A new human oral challenge model with wild-type Salmonella Typhi (S. Typhi) was recently developed. In this model, 104 CFU resulted in 65% of participants developing typhoid fever (TD) 5-10 days post-challenge. TD was diagnosed in participants meeting clinical (≥38°C for ≥12h) and/or microbiological (bacteremia) endpoints. Changes in B cells subpopulations following S. Typhi challenge remain to be explored. To address this, a subset of volunteers (6 TD and 4 who did not develop TD -NoTD-) was evaluated. The most notable changes included an increase in plasmablasts frequency during disease days (TD-0h to TD-96h).  Plasmablasts also showed enhanced binding to S. Typhi, decreased expression of IgA and increased expression of CD21. Additionally, the percentages of B memory subsets (IgD/CD27 classification) were decreased during disease days, most notably in switched (Sm) and unswitched (Um) memory cells. Of note, IgA expression was upregulated in Sm cells. Moreover, the percentages of Sm CD27+ cells phosphorylating Erk1/2, p38MAPK and Btk were increased during disease days. These changes were absent in NoTD volunteers. This is the first study to describe differences in B cell subsets related directly to clinical outcome following oral challenge with wild-type S. Typhi.